SK bioscience, Gates Foundation to deepen cooperation on global health

SK bioscience, the biotech arm of Korea's SK Group, said Thursday it will expand cooperation with the Gates Foundation on next-generation preventive medicines, with a focus on research and development (R&D) for pandemic preparedness. Officials from SK bioscience and the foundation held a meeting in Seoul on Wednesday to discuss collaboration on vaccine development and global public health projects, the company said in a press release. The meeting came amid Bill Gates' ongoing trip to Korea that began Wednesday. The two sides have previously worked together on several projects, including the development of vaccines for typhoid and pediatric diarrhea, as well as other antiviral preventive solutions, it said. One of their key achievements was the joint development of SKYCovione, Korea's first domestically developed COVID-19 vaccine, which was commercialized for domestic use in 2022. Gates, who has led global initiatives on climate change, poverty reduction and public health through the foundation, is visiting Korea to explore possible cooperation with local pharmaceutical companies on a vacWeiter zum vollständigen Artikel bei Korea Times Weiter zum vollständigen Artikel bei Korea Times